Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endometrial Cancer
Factors influencing vaginal relapse in stage I endometrial cancer
September 15th, 2005
Researchers in the United States conducted a study "to identify factors predictive of vaginal relapse in stage I endometrial cancer, thereby potentially facilitating the selection of patients who may benefit from vaginal brachytherapy. The study population included 632 patients with stage I endometrial cancer managed with hysterectomy at our institution between 1984 and 1996." "Median follow-up was 73 months; 122 patients (19%) received adjuvant radiotherapy," wrote A. Mariani and colleagues. "Overall, 2.9% of the stage I cohort developed vaginal relapse at 5 years. Vaginal relapse was observed in 1.7% of patients who received radiotherapy and in 3.0% of those whose...
Source: Women's Health Weekly (2005-09-15)
|
